Form 4 for OPXS Optex Systems Holdings Inc
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-05 · accession 0001493152-25-026867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | 2025-12-05 | OPXS | SCHOENING DANNY ROBERT | CEO, Dir, 10% | A - Grant | $14.33 | +4,700 | 907.3K | +0.5% | +$67.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | A | A | 4,700 | $14.33 | 907,308 | D | — | — | (F1) 100% vesting on January 1, 2027. The NASDAQ closing price per share of common stock on the date of grant was $14.33 |